Alterity Therapeutics Halts Trading, Citing Exhibit 99.1

TL;DR

**Alterity Therapeutics just announced a trading halt, so watch for upcoming news!**

AI Summary

Alterity Therapeutics Limited, a foreign private issuer, filed a Form 6-K on February 22, 2024, indicating a trading halt. This filing is incorporated by reference into several of their existing Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076). The company, based in Melbourne, Victoria, Australia, operates in the pharmaceutical preparations industry.

Why It Matters

A trading halt can signal significant news, either positive or negative, that could impact investor confidence and the company's stock price once trading resumes.

Risk Assessment

Risk Level: medium — A trading halt introduces uncertainty, as the reason for the halt is not disclosed in this filing, potentially leading to significant price movement upon resumption.

Key Players & Entities

• Alterity Therapeutics Limited (company) — Registrant and foreign private issuer
• February 2024 (date) — Month of report
• Melbourne, Victoria 3000 Australia (location) — Principal Executive Office address
• 333-251073 (other) — Form S-8 File Number
• 333-274816 (other) — Form F-3 File Number

FAQ

Filing Documents

• ea0200447-6k_alterity.htm (6-K) — 13KB
• ea0200447ex99-1_alterity.htm (EX-99.1) — 14KB
• ex99-1_001.jpg (GRAPHIC) — 2KB
• ex99-1_002.jpg (GRAPHIC) — 1KB
• ex99-1_003.jpg (GRAPHIC) — 4KB
• 0001213900-24-015887.txt ( ) — 38KB

From the Filing

OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Trading Halt 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: February 22 , 2024 2

View Full Filing

View this 6-K filing on SEC EDGAR